GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealing Clinical Execution Failures: Levi & Korsinsk...
Gossamer Bio, Inc. (GOSS)
Last gossamer bio, inc. earnings: 3/24 07:00 am
Check Earnings Report
Company Research
Source: GlobeNewswire
NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP reminds purchasers of Gossamer Bio, Inc. (NASDAQ: GOSS) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased Gossamer securities between June 16, 2025 and February 20, 2026. YOUR OPTIONS: You may be entitled to compensation without payment of any out-of-pocket fees. See if you can recover losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500. Gossamer shares collapsed from $2.13 to $0.42 on February 23, 2026, destroying over 80% of shareholder value in a single trading session, after topline Phase 3 PROSERA results revealed the study failed to meet its primary endpoint. Investors have until June 1, 2026 to seek lead plaintiff status. How a Clinical-Stage Biopharma Company Monitors Trial Execution A clinical-stage biopharmaceutical company sponsoring a global Phase 3 trial bears responsibility for mon
Show less
Read more
Impact Snapshot
Event Time:
GOSS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GOSS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GOSS alerts
High impacting Gossamer Bio, Inc. news events
Weekly update
A roundup of the hottest topics
GOSS
News
- GOSS Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Gossamer Bio, Inc. Class Action LawsuitGlobeNewswire
- Law Offices of Frank R. Cruz Encourages Gossamer Bio, Inc. (GOSS) Shareholders To Inquire About Securities Fraud Class ActionBusiness Wire
- Law Offices of Howard G. Smith Encourages Gossamer Bio, Inc. (GOSS) Shareholders To Inquire About Securities Fraud Class ActionBusiness Wire
- Bronstein, Gewirtz & Grossman LLC Urges Gossamer Bio, Inc. Investors to Act: Class Action Filed Alleging Investor HarmGlobeNewswire
- Gossamer Bio, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GOSSPR Newswire
GOSS
Earnings
- 3/17/26 - Miss
GOSS
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/24/26 - Form SCHEDULE
- 3/20/26 - Form 4
- GOSS's page on the SEC website